Mapping community pharmacy services in Brazil

a scoping review

Authors

  • Aline Ansbach Garabeli Pharmaceutical Sciences Postgraduate Programme, Federal University of Paraná, Curitiba, PR, Brazil
  • Arcelio Benetoli Department of Pharmaceutical Sciences, State University of Ponta Grossa, PR, Brazil
  • Gerusa Clazer Halila Department of Pharmaceutical Sciences, State University of Ponta Grossa, PR, Brazil
  • Isadora Machinski Department of Pharmaceutical Sciences, State University of Ponta Grossa, PR, Brazil
  • Fernanda Stumpf Tonin Pharmaceutical Sciences Postgraduate Programme, Federal University of Paraná, Curitiba, PR, Brazil
  • Fernando Fernandez-Llimos Laboratory of Pharmacology, Department of Drug Sciences, University of Porto, Porto, Portugal
  • Roberto Pontarolo Department of Pharmacy, Federal University of Paraná, Curitiba, PR, Brazil https://orcid.org/0000-0002-7049-4363

DOI:

https://doi.org/10.1590/s2175-97902022e20851

Keywords:

Community pharmacy services; Pharmacists; Pharmacy research; Terminology; Public Reporting of Healthcare Data

Abstract

The delivery of clinical pharmacy services has been growing in Brazilian community pharmacies, and it is necessary to have a comprehensive understanding of the topic. This scoping review aimed to provide an overview of Brazilian studies about clinical pharmacy services in community pharmacies. Original research articles, with no restriction of time, study design, or patient’s health condition, were included. Searches were conducted in PubMed, Scopus, Web of Science, Scielo, and Lilacs. Two reviewers conducted the screening, full-text reading, and data extraction independently. ROB and ROBINS-I were used for the assessment of quality. Charts and tables were built to summarise the data. Seventy-two articles were included. A diversity of study designs, number of participants, terms used, and outcomes was found. São Paulo and Sergipe States had the highest number of studies (n=10). Pharmacists’ interventions were not fully reported in 65% of studies, and most studies presented an unclear risk of bias. Studies were very diverse, impairing the comparisons between the results and hindering their reproducibility. This review suggests using guidelines and checklists for better structuration of pharmacists’ interventions as well as reporting results and measuring fidelity in future research.

Downloads

Download data is not yet available.

References

ABRAFARMA. Associação Brasileira de Redes de Farmácias e Drogarias. Uma nova era da saúde no país. Excelência. 2017;7(7):12-8. Available from: www.abrafarma.com.br

» www.abrafarma.com.br

Abrahamsen B, Burghle AH, Rossing C. Pharmaceutical care services available in Danish community pharmacies. Int J Clin Pharm. 2020;42(2):315-20.

Academia Brasileira de Ciências (ABC). Universidades públicas respondem por mais de 95% da produção científica do Brasil. [Internet]. 2019. [cited 2020 Nov 16]. Available from: Available from: http://www.abc.org.br/2019/04/15/universidades-publicas-respondem-por-mais-de-95-da-producao-cientifica-do-brasil/

» http://www.abc.org.br/2019/04/15/universidades-publicas-respondem-por-mais-de-95-da-producao-cientifica-do-brasil/

Aguiar PM, Balisa-Rocha BJ, Brito GC, Lyra DP. Pharmaceutical care program for elderly patients with uncontrolled hypertension. J Am Pharm Assoc. 2012;52(4):515-8.

Aguiar PM, Balisa-Rocha BJ, Lyra-Júnior DP. Avaliação de indicadores de estrutura e processo de um serviço de Atenção Farmacêutica na Farmácia Popular do Brasil: um estudo piloto. Rev Ciências Farm Básica Apl. 2013;34(3):401-10.

Ajalla M, Castro L. Contribuição para melhoria da prática farmacêutica no atendimento de pacientes com queixas referentes a doenças sexualmente transmissíveis, em Campo Grande-MS. Rev Ciências Farm. 2003;24(2):121-30.

Alhusein N, Watson MC. Quality indicators and community pharmacy services: a scoping review. Int J Pharm Pract. 2019;27(6):490-500.

American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service model. American Pharmacists Association and National Association of Chain Drug Stores Foundation; 2008. 24p.

Andrade TU, Burini DM, Mello M de O, Bersácula N dos S, Saliba RAD, Bravim FT, et al. Evaluation of the satisfaction level of patients attended by a Pharmaceutical Care Program in a Private Communitarian Pharmacy in Vitória (ES, Brazil). Brazilian J Pharm Sci. 2009;45(2):349-55.

Araújo P, Costa E, Guerra Junior A, Acurcio F, Guibu I, Álvares J, et al. Pharmaceutical care in Brazil’s primary health care. Rev Saude Publica. 2017;51:1s-11s.

Bonetti AF, Della Rocca AM, Lucchetta RC, Tonin FS, Fernandez-Llimos F, Pontarolo R. Mapping the characteristics of meta-analyses of pharmacy services: a systematic review. Int J Clin Pharm . 2020;42(5):1252-60.

Brasil. Lei no 13.021, de 08 de agosto de 2014. Dispõe sobre o controle sanitário do comércio de drogas, medicamentos, insumos farmacêuticos e correlatos. Diário Oficial da União, Poder Executivo, Brasília/DF, 2014. Available from: https://www2.camara.leg.br/legin/fed/lei/2014/lei-13021-8-agosto-2014-779151-normaatualizada-pl.pdf.

» https://www2.camara.leg.br/legin/fed/lei/2014/lei-13021-8-agosto-2014-779151-normaatualizada-pl.pdf.

Brasil. Ministério da Educação. Conselho Nacional de Educação. Câmara de Educação Superior. Resolução no 6 de 19 de outubro de 2017. Institui as Diretrizes Curriculares Nacionais do Curso de Graduação em Farmácia e dá outras providências. Diário Oficial da União , Poder Executivo. Brasília/DF, 2017. Seção 1, p. 30. Available from: http://portal.mec.gov.br/docman/outubro-2017-pdf/74371-rces006-17-pdf/file

» http://portal.mec.gov.br/docman/outubro-2017-pdf/74371-rces006-17-pdf/file

Brasil. Ministério da Saúde. Agência Nacional De Vigilância Sanitária. Resolução RDC no. 44, de 17 de agosto de 2009. Dispõe sobre boas práticas farmacêuticas para o controle sanitário do funcionamento, da dispensação e da comercialização de produtos e da prestação de serviços farmacêuticos em farmácias e drogarias e dá outras providências. Diário Oficial da União , Poder Executivo, Brasília/DF , 2009. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2009/rdc0044_17_08_2009.html

» http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2009/rdc0044_17_08_2009.html

Brasil. Ministério da Saúde. Portaria no 1.214, de 13 de junho de 2012. Institui o Programa Nacional de Qualificação da Assistência Farmacêutica no âmbito do Sistema Único de Saúde (QUALIFAR-SUS). Diário Oficial da União , Poder Executivo Brasília/DF, 2012. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2012/prt1214_13_06_2012.html

» http://bvsms.saude.gov.br/bvs/saudelegis/gm/2012/prt1214_13_06_2012.html

Brasil. Ministério da Saúde. Portaria nº 4.279, de 30 dezembro de 2010. Estabelece diretrizes para a organização da Rede de Atenção à Saúde no âmbito do Sistema Único de Saúde (SUS). Diário Oficial da União , Poder Executivo, Brasília/DF , 2010. 31 dez. 2010. Seção 1, p. 89. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2010/prt4279_30_12_2010.html

» http://bvsms.saude.gov.br/bvs/saudelegis/gm/2010/prt4279_30_12_2010.html

Cadore L, Marc C, Berti C, Peukert C, Machado A. Pharmacy distribution of advice, symptomatic treatment and antimicrobial drugs to patients with cough. Braz J Infect Dis. 1999;3(5):180-3.

Carroll C, Patterson M, Wood S, Booth A, Rick J, Balain S. A conceptual framework for implementation fidelity. Implement Sci. 2007;2:40.

Cazarim M, Freitas O, Penaforte T, Achcar A, Pereira L. Impact assessment of pharmaceutical care in the management of hypertension and coronary risk factors after discharge. PLoS One. 2016;11(6):2006-8.

Cazarim M, Nunes AA, Pereira LRL. Cost-consequence analysis of Pharmaceutical Care program for systemic arterial hypertension in the public health system in Brazil. Braz J Pharm Sci. 2017;53(3):1-10.

Cazarim M, Pereira L. Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil. PLoS One . 2018;13(3):1-16.

Clancy MJ. Overview of research designs. Emerg Med J. 2002;19(6):546-9.

Clay PG, Burns AL, Isetts BJ, Hirsch JD, Kliethermes MA, Planas LG. PaCIR: A tool to enhance pharmacist patient care intervention reporting. J Am Pharm Assoc . 2019;59(5):615-23.

Conselho Federal de Farmácia (CFF). Serafin C, Correia Júnior D, Vargas M. Perfil do farmacêutico no Brasil: relatório. Brasília: Conselho Federal de Farmácia; 2015. 44p. Available from: https://www.cff.org.br/userfiles/file/Perfil do farmacêutico no Brasil_web.pdf

» https://www.cff.org.br/userfiles/file/Perfil do farmacêutico no Brasil_web.pdf

Conselho Federal de Farmácia (CFF). Resolução no 585, de 29 de agosto de 2013. Regulamenta as atribuições clínicas do farmacêutico e dá outras providências. Diário Oficial da União , Poder Executivo, Brasília/DF ; 2013a. Seção 1, p. 186-188. Available from: https://www.cff.org.br/userfiles/file/resolucoes/585.pdf

» https://www.cff.org.br/userfiles/file/resolucoes/585.pdf

Conselho Federal de Farmácia (CFF). Resolução no 586, de 29 de agosto de 2013. Regula a prescrição farmacêutica e dá outras providências. Diário Oficial da União , Poder Executivo, Brasília/DF ; 2013b. Seção 1, p. 136-138. Available from: https://www.cff.org.br/userfiles/file/resolucoes/586.pdf

» https://www.cff.org.br/userfiles/file/resolucoes/586.pdf

Conselho Federal de Farmácia (CFF). Serviços farmacêuticos diretamente destinados ao paciente, à família e à comunidade: contextualização e arcabouço conceitual. 1a Brasília: Conselho Federal de Farmácia ; 2016a.

Conselho Federal de Farmácia (CFF). Guia de prática clínica: sinais e sintomas respiratórios. Brasília: Conselho Federal de Farmácia ; 2016b. 168p.

Conselho Federal de Farmácia (CFF). Guia de prática clínica: sinais e sintomas do aparelho genital feminino. Brasília: Conselho Federal de Farmácia ; 2017. 218p.

Conselho Federal de Farmácia (CFF). Guia de prática clínica: sinais e sintomas não específicos. Brasília: Conselho Federal de Farmácia ; 2018. 122p.

Conselho Federal de Farmácia (CFF). Guia de prática clínica: sinais e sintomas do trato gastrintestinal. Brasília: Conselho Federal de Farmácia ; 2020. 200p.

Correr CJ, Otuki MF. A prática farmacêutica na farmácia comunitária. 1st ed. Porto Alegre: Artmed; 2013. 440p.

Costa EA, Araújo PS, Penaforte TR, Barreto JL, Guerra Junior AA, Acurcio F de A, et al. Conceptions on pharmaceutical services in Brazilian primary health care. Rev Saude Publica . 2017;51(suppl 2):5S.

Costa S, Cary M, Helling DK, Pereira J, Mateus C. An overview of systematic reviews of economic evaluations of pharmacy-based public health interventions: addressing methodological challenges. Syst Rev. 2019;8(272):1-20.

Craig P, Dieppe P, Macintyre S, Mitchie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ. 2008;337:a1655:979-83.

De Barra M, Scott C, Johnston M, De Bruin M, Scott N, Matheson C, et al. Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review. BMJ Open. 2019;9(12):1-8.

Detoni KB, Oliveira I V, Nascimento MMG, Caux TR, Alves MR, Ramalho-De-Oliveira D. Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease. Int J Clin Pharm . 2017;39(1):95-103.

Dosea AS, Brito GC, Santos LM, Marques TC, Balisa-Rocha B, Pimentel D, et al. Establishment, implementation, and consolidation of clinical pharmacy services in community pharmacies: perceptions of a group of pharmacists. Qual Health Res. 2017;27(3):363-73.

Durlak JA, DuPre EP. Implementation matters: A review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Community Psychol. 2008;41(3-4):327-50.

Elm E von, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-8.

Fegadolli C, Cavaco AM, Fonseca DC. Revisiting concepts, attitudes and expectations of Brazilian pharmacists to the practice of pharmaceutical care: a qualitative perspective. Indian J Pharm Educ Res. 2018;52(1):1-9.

Firmino PYM, Vasconcelos TO, Ferreira CC, Moreira LM, Romero NR, Dias LA, et al. Cardiovascular risk rate in hypertensive patients attended in primary health care units: The influence of pharmaceutical care. Braz J Pharm Sci . 2015;51(3):617-28.

França Filho JB, Correr CJ, Rossignoli P, Melchiors AC, Fernández-Llimós F, Pontarolo R. Perfil dos farmacêuticos e farmácias em Santa Catarina: indicadores de estrutura e processo. Rev Bras Ciências Farm. 2008;44(1):105-13.

Franceschet I, Farias MR. Investigação do perfil dos farmacêuticos e das atividades desenvolvidas em farmácias do setor privado no município de Florianópolis, Santa Catarina, Brasil. Acta Farm Bonaer. 2005;24(4):590-7.

Galato D, Alano GM, Trauthman SC, França TF. Pharmacy practice simulations: performance of senior pharmacy students at a University in southern Brazil. Pharm Pract. 2011;9(3):136-40.

Garabeli AA, Daher JB, Wiens A, Lenzi L, Pontarolo R. Quality of life perception of type 1 diabetic patients treated with insulin analogs and receiving medication review with follow-up in a public health care service from ponta Grossa-PR, Brazil. Braz J Pharm Sci . 2016;52(4):669-78.

Gerenutti M, Martinez AMV, Bergamaschi CC. The effectiveness of a pharmaceutical care model on adherence to antiretroviral therapy: A same-based cohort study in Brazil. Adv Pharm Bull. 2017;7(3):469-72.

Gomes LO, Teixeira MR, Rosa JA da, Foppa AA, Rover MRM, Farias MR. The benefits of a public pharmacist service in chronic hepattis C treatment: the real-life results of sofosbuvir-based therapy. Res Soc Adm Pharm. 2020;16(1):48-53.

Halila GC, Junior EH, Otuki MF, Correr CJ. The practice of OTC counseling by community pharmacists in Parana, Brazil. Pharm Pract . 2015;13(4):1-8.

Hipólito Júnior E, Halila GC, Christini W, Reis T, Guimarães MM, Guanaes LD, et al. Quality indicators of pharmacists’ services in community pharmacies in Paraná State, Brazil. Braz J Pharm Sci . 2017;53(1):1-9.

IBGE - Centro Brasileiro de Geografia e Estatística. Sinopse do Censo Demográfico 2010. [cited 2020 May 15]. Available from: Available from: https://censo2010.ibge.gov.br/sinopse/index.php?dados=10&uf=00

» https://censo2010.ibge.gov.br/sinopse/index.php?dados=10&uf=00

Imfeld-Isenegger TL, Soares IB, Makovec UN, Horvat N, Kos M, van Mil F, et al. Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration. Res Soc Adm Pharm . 2019;16(8):1057-66.

INEP - Instituto Nacional de Estudos e Pesquisas Educacionais Anísio Teixeira. Censo da Educação Superior: Sinopse Estatística da Educação Superior, 2018. [cited 2020 May 17]. Available from: Available from: http://portal.inep.gov.br/web/guest/sinopses-estatisticas-da-educacao-superior

» http://portal.inep.gov.br/web/guest/sinopses-estatisticas-da-educacao-superior

Leite SN, Bernardo NLM da C, Álvares J, Guerra Junior AA, Costa EA, Acurcio F de A, et al. Medicine dispensing service in primary health care of SUS. Rev Saude Publica . 2017;51(2):1s-10s.

Lima MG, Álvares J, Guerra Junior AA, Costa EA, Guibu IA, Soeiro OM, et al. Indicators related to the rational use of medicines and its associated factors. Rev Saude Publica . 2017;51(suppl 2):23S.

Lyra Jr DP, Kheir N, Abriata JP, da Rocha CE, dos Santos CB, Pelá IR. Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil. Ther Clin Risk Manag. 2007;3(6):989-98.

Melo DO, Castro LLC. Pharmacist’s contribution to the promotion of access and rational use of essential medicines in SUS. Cienc Saude Coletiva. 2017a;22(1):235-44.

Melo DO, Molino CGC, Ribeiro E, Romano-Lieber NS. Capacitação e intervenções de técnicos de farmácia na dispensaçãvo de medicamentos em atenção primária à saúde. Cienc Saude Coletiva . 2017b;22(1):261-8.

Mendes EV. Health care networks. Cienc Saude Colet. 2010;15(5):2297-305.

Mendonça SM, Melo AC, Pereira GC, dos Santos D, Grossi EB, Sousa M, et al. Clinical outcomes of medication therapy management services in primary health care. Braz J Pharm Sci . 2016;52(3):365-73.

Mesquita AR, Sá DAB de O, Santos APAL, Neto A de A, Lyra-Júnior DP. Assessment of pharmacist’s recommendation of non-prescription medicines in Brazil: a simulated patient study. Int J Clin Pharm . 2013;35(4):647-55.

Moullin JC, Sabater-Hernández D, Benrimoj SI. Model for the evaluation of implementation programs and professional pharmacy services. Res Soc Adm Pharm . 2016a;12(3):515-22.

Moullin JC, Sabater-Hernández D, Benrimoj SI. Qualitative study on the implementation of professional pharmacy services in Australian community pharmacies using framework analysis. BMC Health Serv Res. 2016b;16(1):1-13.

Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj SI. A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework. Heal Res Policy Syst. 2015;13:16.

Mourão AOM, Ferreira WR, Martins MAP, Reis AMM, Carrillo MRG, Guimarães AG, et al. Pharmaceutical care program for type 2 diabetes patients in Brazil: A randomised controlled trial. Int J Clin Pharm . 2013;35(1):79-86.

National Association of Pharmacy Regulatory Authorities (NAPRA). Model standards for practice for Canadian pharmacists. Ottawa: The National Association of Pharmacy Regulatory Authorities; 2009. 18p.

Nedel WL, Silveira F. Different research designs and their characteristics in intensive care. Rev Bras Ter Intensiva. 2016;28(3):256-60.

Obreli-Neto PR, Guidoni CM, Baldoni A de O, Pilger D, Cruciol-Souza JM, Gaeti-Franco WP, et al. Effect of a 36-Month Pharmaceutical Care Program on Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients. J Pharm Pharm Sci. 2011a;14(2):249-63.

Obreli-Neto PR, Guidoni CM, Baldoni A de O, Pilger D, Cruciol-Souza J, Gaeti-Franco WP, et al. Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm . 2011b;33(4):642-9.

Obreli-Neto PR, Marusic S, Guidoni CM, Baldoni A de O, Renovato RD, Pilger D, et al. Economic evaluation of a Pharmaceutical Care Program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trial. J Manag Care Spec Pharm. 2015;21(1):66-75.

Oliveira NVBV de, Szabo I, Bastos LL, Paiva SP. Atuação profissional dos farmacêuticos no brasil: perfil sociodemográfico e dinâmica de trabalho em farmácias e drogarias privadas. Saude Soc. 2017;26(4):1105-21.

Paim J, Travassos C, Almeida C, Bahia L, MacInko J. The Brazilian health system: History, advances, and challenges. Lancet. 2011;377(9779):1778-97.

Patwardhan PD, Amin ME, Chewning BA. Intervention research to enhance community pharmacists’ cognitive services: A systematic review. Res Soc Adm Pharm . 2014;10(3):475-93.

Pharmacy Board of Australia. Guidelines for dispensing of medicines; 2015. p. 1-16.

Plaster CP, Melo DT, Boldt V, Cassaro KO dos S, Lessa FCR, Boëchat GAP, et al. Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up. Braz J Pharm Sci . 2012;48(3):435-46.

Reis TM, Rocha KSS, Barros IMC, Santos LMC, Paixão FP, Almeida FHO, et al. Pharmacists’ Skills in Conducting Clinical Services in Community Pharmacies in Urban Areas of Northeast Brazil. Lat Am J Pharm. 2015;34(4):725-31.

Rocha C, Bispo M, Alcantara T, Brito G, Vieira M, Lyra D. What do Brazilian community pharmacists know about self-medication for minor illnesses? A pilot study in the northeast of Brazil. J Appl Pharm Sci. 2014;4(5):12-20.

Rocha C, Bispo M, dos Santos A, Mesquita A, Brito G, Lyra D. Assessment of community pharmacists’ counseling practices with simulated patients who have minor illness. Simul Healthc J Soc Simul Healthc. 2015;10(4):227-38.

Rotta I, Salgado TM, Felix DC, Souza TT, Correr CJ, Fernandez-Llimos F. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: An improved version of DEPICT. J Eval Clin Pract. 2015a;21(4):584-90.

Rotta I, Salgado TM, Silva ML, Correr CJ, Fernandez-Llimos F. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000-2010). Int J Clin Pharm . 2015b;37(5):687-97.

Rotta I, Souza TT, Salgado TM, Correr CJ, Fernandez-Llimos F. Characterization of published randomized controlled trials assessing clinical pharmacy services around the world. Res Soc Adm Pharm . 2017;13(1):201-8.

Santos A, Mesquita A, Oliveira K, Lyra D. Assessment of community pharmacists´ counselling skills on headache management by using the simulated patient approach: a pilot study. Pharm Pract . 2013;11(1):3-7.

Santos BD, Nascimento MMG do, de Oliveira GCB, Nascimento Y de A, Mambrini JV de M, Cid AS, et al. Clinical impact of a comprehensive medication management service in primary health care. J Pharm Pract . 2021;34(2):265-271.

Santos Júnior GA, Silva ROS, Onozato T, Silvestre CC, Rocha KSS, Araújo EM, et al. Implementation of clinical pharmacy services using problematization with Maguerez Arc: a quasi-experimental before-after study. J Eval Clin Pract . 2020;27(2):391-403.

Scarabelin A, Santana Dosea A, Aguiar PM, Storpirtis S. Pharmacist-patient communication in prostate cancer as a strategy to humanize health care: a qualitative study. J Patient Exp. 2019;6(2):150-6.

Silva BB, Fegadolli C. Implementation of pharmaceutical care for older adults in the brazilian public health system: a case study and realistic evaluation. BMC Health Serv Res . 2020;20(37):2-14.

Silva G, Bazotte RB. Development and evaluation of a Pharmaceutical Care Program to reduce modifiable risk of chronic complications in Brazilian type 2 diabetic patients. Lat Am J Pharm . 2011;30(1):154-60.

Soeiro OM, Tavares NUL, Nascimento JM do, Guerra AA, Costa EA, Acurcio F de A, et al. Patient satisfaction with pharmaceutical services in Brazilian primary health care. Rev Saude Publica . 2017;51( suppl 2):21s.

Souza GS, Costa EA, Barros RD, Pereira MT, Barreto JL, Guerra Junior AA, et al. Caracterização da institucionalização da assistência farmacêutica na atenção básica no Brasil. Rev Saude Publica . 2017;51( suppl 2):1s-12s.

Sterne J, Hernán M, Reeves B, Savović J, Berkman N, Viswanathan M, et al. Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I): detailed guidance. BMJ. 2016;355:i4919.

The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions. Chichester, West Sussex, England: Wiley-Blackwell; 2008.

The Joanna Briggs Institute. The Joanna Briggs Institute Reviewers’ Manual 2015. Adelaide, SA Australia: The Joanna Briggs Institute; 2015: 24p.

Tonin FS, Lopes LA, Rotta I, Bonetti AF, Pontarolo R, Correr CJ, et al. Usability and sensitivity of the risk of bias assessment tool for randomized controlled trials of pharmacist interventions. Int J Clin Pharm . 2019;41(3):785-92.

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467-73.

van der Laan DM, Langendoen-Gort M, Nijpels G, Boons CCLM, Elders PJM, Hugtenburg JG. Implementation fidelity of an intervention programme to enhance adherence to antihypertensive medication in Dutch community pharmacies. Int J Clin Pharm . 2019;41(4):1031-46.

Varas-Doval R, Gastelurrutia MA, Benrimoj SI, Zarzuelo MJ, Garcia-Cardenas V, Perez-Escamilla B, et al. Evaluating an implementation programme for medication review with follow-up in community pharmacy using a hybrid effectiveness study design: Translating evidence into practice. BMJ Open. 2020; 10(9):36669.

von Thiele Schwarz U, Hasson H, Lindfors P. Applying a fidelity framework to understand adaptations in an occupational health intervention. Work. 2015;51(2):195-203.

Web of Science Group. Research in Brazil: Funding excellence. Clarivate Anal. Co.; 2019.

World Health Organization. The legal and regulatory framework for community pharmacies in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2019.

Downloads

Published

2023-02-15

Issue

Section

Review

How to Cite

Mapping community pharmacy services in Brazil: a scoping review. (2023). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e20851